Ranolazine Improves Angina in Women With Evidence of Myocardial Ischemia But No Obstructive Coronary Artery Disease | Zendy

Puja K. Mehta | Zendy; Pavel Goykhman | Zendy; Louise Thomson | Zendy; Chrisandra Shufelt | Zendy; Janet Wei | Zendy; Yuching Yang | Zendy; Edward Gill | Zendy; Margo Minissian | Zendy; Leslee J. Shaw | Zendy; Piotr J. Slomka | Zendy; Melissa Slivka | Zendy; Daniel S. Berman | Zendy; C. Noel Bairey Merz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ranolazine Improves Angina in Women With Evidence of Myocardial Ischemia But No Obstructive Coronary Artery Disease

Author(s) -

Puja K. Mehta,

Pavel Goykhman,

Louise Thomson,

Chrisandra Shufelt,

Janet Wei,

Yuching Yang,

Edward Gill,

Margo Minissian,

Leslee J. Shaw,

Piotr J. Slomka,

Melissa Slivka,

Daniel S. Berman,

C. Noel Bairey Merz

Publication year - 2011

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2011.03.007

Subject(s) - ranolazine , medicine , cardiology , angina , coronary artery disease , placebo , ischemia , myocardial perfusion imaging , myocardial infarction , alternative medicine , pathology

We conducted a pilot study for a large definitive clinical trial evaluating the impact of ranolazine in women with angina, evidence of myocardial ischemia, and no obstructive coronary artery disease (CAD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research